It is a fact with humans that they fear that of which they know not instead of being assured by that they know.
A corporation, no matter how dominant in their field, is always wary of the competition. I worked as a rep for many fine engineered fastener companies and all were paranoid about the competition and made it sound as though they walked on water.
Then they talked about all the weaknesses in their own company and acted surprised they had any business at all, even if they were the world leader in that specific product.
WE KNOW Brilacidin is a completely new arm of medicine with so many anti-XXX properties I get tired naming them, it has shown a remarkably stellar safety profile,it has transferred results wonderfully from in vitro to in vivo, it has shown the ability in all testing to date to handle the entire range of corona viruses,and it is not outrageously costly by any means.
So with what we KNOW we have and that new arms of medicine don't come around every day, that over the last 2 years there has been nothing offered by the BPs who have been given money to come up with something by the truckloads, that the CV variants are getting harder and harder for anything to conquer -
WHY DO WE BLITHER ABOUT REGARDING COMPETITION??
If someone comes up with something of any value, so be it, great for them. But does anybody really see such a COMPLETE PACKAGE coming about within the next month OTHER THAN BRILACIDIN that could possibly even come close to working such as what we will offer??
My suggestion is to not worry now because the threat of a world changing treatment other than Brilacidin is IMO highly unlikely and IPIX will fare quite well even if a competitor came on the market.
The only possible improvement to Brialcidin IMO is a pill or spray delivery system and I believe those issues are being currently addressed behind the scene.
